Free Trial

Bio-Techne (TECH) News Today

Bio-Techne logo
$50.49 +0.86 (+1.73%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$50.52 +0.03 (+0.06%)
As of 05/2/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Bio-Techne Co. stock logo
Aquatic Capital Management LLC Buys New Stake in Bio-Techne Co. (NASDAQ:TECH)
Aquatic Capital Management LLC purchased a new position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,825 shares of the biotechnology compa
Analysts Set Bio-Techne Co. (NASDAQ:TECH) Price Target at $81.14
Bio-Techne Co. stock logo
Freestone Grove Partners LP Invests $30.05 Million in Bio-Techne Co. (NASDAQ:TECH)
Freestone Grove Partners LP acquired a new position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 417,143 shares of the biotechnology company's stock, valued at approximately $30
Bio-Techne Co. stock logo
Dimensional Fund Advisors LP Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)
Dimensional Fund Advisors LP increased its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 5.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 953,786 shares of the biotechnolo
Bio-Techne Co. stock logo
Bio-Techne (TECH) Expected to Announce Earnings on Wednesday
Bio-Techne (NASDAQ:TECH) will be releasing its Q3 2025 earnings before the market opens on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-bio-techne-co-stock/)
Bio-Techne Co. stock logo
First Trust Advisors LP Sells 10,263 Shares of Bio-Techne Co. (NASDAQ:TECH)
First Trust Advisors LP cut its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 10.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,283 shares of the biotechnology com
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Rating of "Hold" from Analysts
Bio-Techne Co. (NASDAQ:TECH - Get Free Report) has received a consensus rating of "Hold" from the eight research firms that are currently covering the firm, MarketBeat reports. Five research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The av
Bio-Techne Co. stock logo
Hsbc Holdings PLC Raises Position in Bio-Techne Co. (NASDAQ:TECH)
Hsbc Holdings PLC grew its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 8.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 268,472 shares of the biotechnology company's stock after acquiring an additional 21,483 shares during the
Bio-Techne Co. stock logo
Tower Research Capital LLC TRC Acquires 7,129 Shares of Bio-Techne Co. (NASDAQ:TECH)
Tower Research Capital LLC TRC grew its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 193.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,823 shares of the biotechnology company's stoc
Bio-Techne Co. stock logo
Voya Investment Management LLC Grows Holdings in Bio-Techne Co. (NASDAQ:TECH)
Voya Investment Management LLC raised its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 439,588 shares of the biotechnology
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Snyder Capital Management L P
Snyder Capital Management L P boosted its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 6.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,127,380 shares of the biotechnology company's s
Bio-Techne Co. stock logo
Adage Capital Partners GP L.L.C. Acquires 175,000 Shares of Bio-Techne Co. (NASDAQ:TECH)
Adage Capital Partners GP L.L.C. increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 54.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 498,500 shares of the biotechnology company's stock
Bio-Techne Co. stock logo
Price T Rowe Associates Inc. MD Has $767.43 Million Stake in Bio-Techne Co. (NASDAQ:TECH)
Price T Rowe Associates Inc. MD lifted its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 13.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,654,267 shares of the biotech
Bio-Techne Co. stock logo
Natixis Acquires New Shares in Bio-Techne Co. (NASDAQ:TECH)
Natixis bought a new position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 10,412 shares of the biotechnology company's stock,
Bio-Techne Co. stock logo
Wells Fargo & Company MN Sells 34,826 Shares of Bio-Techne Co. (NASDAQ:TECH)
Wells Fargo & Company MN decreased its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 40.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 51,397 shares of the biotechnology company's stock after selling 34,82
Bio-Techne Co. stock logo
Eversept Partners LP Lowers Stake in Bio-Techne Co. (NASDAQ:TECH)
Eversept Partners LP cut its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 54.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 299,310 shares of the biotechnology company's stock after selling 364,26
Bio-Techne Co. stock logo
Bio-Techne (NASDAQ:TECH) Hits New 52-Week Low - Should You Sell?
Bio-Techne (NASDAQ:TECH) Hits New 12-Month Low - What's Next?
Bio-Techne Co. stock logo
BI Asset Management Fondsmaeglerselskab A S Acquires 270,516 Shares of Bio-Techne Co. (NASDAQ:TECH)
BI Asset Management Fondsmaeglerselskab A S raised its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 6,283.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 274,821 shares of the biotechnology company's stock after acquiring an additional
Bio-Techne price target lowered to $51 from $68 at Baird
Bio-Techne Co. stock logo
Q3 EPS Estimates for Bio-Techne Lowered by Leerink Partnrs
Bio-Techne Co. (NASDAQ:TECH - Free Report) - Investment analysts at Leerink Partnrs decreased their Q3 2025 EPS estimates for shares of Bio-Techne in a report issued on Thursday, April 17th. Leerink Partnrs analyst P. Souda now anticipates that the biotechnology company will earn $0.45 per share
Bio-Techne Co. stock logo
Cramer Rosenthal Mcglynn LLC Decreases Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Cramer Rosenthal Mcglynn LLC decreased its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 485,517 shares of t
Bio-Techne Co. stock logo
Champlain Investment Partners LLC Trims Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)
Champlain Investment Partners LLC lowered its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 7.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,419,654 shares of the biotechnology company's stock after
Bio-Techne Co. stock logo
Osterweis Capital Management Inc. Has $17.70 Million Holdings in Bio-Techne Co. (NASDAQ:TECH)
Osterweis Capital Management Inc. boosted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 45.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 245,731 shares of the biotechnology company's stock
Bio-Techne Co. stock logo
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Marshall Wace LLP
Marshall Wace LLP lessened its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 13.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,522,693 shares of the biotechnology c
Bio-Techne Co. stock logo
StockNews.com Upgrades Bio-Techne (NASDAQ:TECH) to Buy
StockNews.com upgraded shares of Bio-Techne from a "hold" rating to a "buy" rating in a research note on Thursday.
Bio-Techne (TECH) Receives a Buy from Leerink Partners
Bio-Techne Co. stock logo
Granite Investment Partners LLC Grows Position in Bio-Techne Co. (NASDAQ:TECH)
Granite Investment Partners LLC grew its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 48.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 136,572 shares of the biotec
Bio-Techne Co. stock logo
Grandeur Peak Global Advisors LLC Sells 6,844 Shares of Bio-Techne Co. (NASDAQ:TECH)
Grandeur Peak Global Advisors LLC cut its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 57.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,125 shares of the biotechnology company's stock after sel
Bio-Techne Co. stock logo
Bank of Montreal Can Trims Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Bank of Montreal Can cut its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 194,356 shares of the biotechnology company's stock after selling 11,197
Bio-Techne Co. stock logo
Envestnet Asset Management Inc. Sells 44,093 Shares of Bio-Techne Co. (NASDAQ:TECH)
Envestnet Asset Management Inc. cut its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 11.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 349,130 shares of the biotechnology company's stock after selling 44,09
Bio-Techne Co. stock logo
93,151 Shares in Bio-Techne Co. (NASDAQ:TECH) Bought by APG Asset Management N.V.
APG Asset Management N.V. purchased a new stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 93,151 shares of the biotechnology company's stock, valued at approximately $6,480,000. APG Asset Management
Bio-Techne Co. stock logo
Legal & General Group Plc Has $51.66 Million Holdings in Bio-Techne Co. (NASDAQ:TECH)
Legal & General Group Plc trimmed its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 22.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 717,222 shares of the biotechnology company's stock after selling 210,18
Bio-Techne Co. stock logo
Russell Investments Group Ltd. Acquires 9,067 Shares of Bio-Techne Co. (NASDAQ:TECH)
Russell Investments Group Ltd. increased its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 6.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,717 shares of the biotechnology company'
Bio-Techne Co. stock logo
KeyCorp Predicts Bio-Techne's Q3 Earnings (NASDAQ:TECH)
Bio-Techne Co. (NASDAQ:TECH - Free Report) - Analysts at KeyCorp issued their Q3 2025 earnings per share estimates for shares of Bio-Techne in a research note issued on Tuesday, April 8th. KeyCorp analyst P. Knight anticipates that the biotechnology company will post earnings of $0.44 per share f
Bio-Techne Co. stock logo
Invesco Ltd. Boosts Stake in Bio-Techne Co. (NASDAQ:TECH)
Invesco Ltd. lifted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 10.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,820,464 shares of the biotechnology company's stock after purchasi
Bio-Techne Co. stock logo
Cerity Partners LLC Has $8.76 Million Holdings in Bio-Techne Co. (NASDAQ:TECH)
Cerity Partners LLC lowered its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 30.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 110,483 shares of the biotechnology company's stock afte
Bio-Techne Co. stock logo
Neuberger Berman Group LLC Increases Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Neuberger Berman Group LLC raised its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,581,778 shares of the biotechnology company's stock after acquiring an additional 65,686
Bio-Techne Co. stock logo
Resona Asset Management Co. Ltd. Purchases New Shares in Bio-Techne Co. (NASDAQ:TECH)
Resona Asset Management Co. Ltd. purchased a new stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 48,459 shares of the biotechnology company'
Bio-Techne Co. stock logo
Bio-Techne (NASDAQ:TECH) Given Sector Weight Rating at KeyCorp
KeyCorp reissued a "sector weight" rating on shares of Bio-Techne in a report on Wednesday.
Bio-Techne Co. stock logo
Aviva PLC Buys 89,289 Shares of Bio-Techne Co. (NASDAQ:TECH)
Aviva PLC grew its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1,546.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,063 shares of the biotechnology company's stock after acquiri
Get Bio-Techne News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.

TECH Media Mentions By Week

TECH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TECH
News Sentiment

1.26

0.73

Average
Medical
News Sentiment

TECH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TECH Articles
This Week

12

9

TECH Articles
Average Week

Get Bio-Techne News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TECH) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners